Clinical Trial: The Effect of Rifabutin in Mycobacterium Abscessus With Inducible Clarithromycin Resistance

U.S., April 8 -- ClinicalTrials.gov registry received information related to the study (NCT07514364) titled 'The Effect of Rifabutin in Mycobacterium Abscessus With Inducible Clarithromycin Resistance... Read More

Clinical Trial: The Association Between Gut Microbiome Composition Signature and Cancer-related Symptoms in Children With Acute Lymphoblastic Leukemia

U.S., April 8 -- ClinicalTrials.gov registry received information related to the study (NCT07515430) titled 'The Association Between Gut Microbiome Composition Signature and Cancer-related Symptoms in... Read More

Clinical Trial: Trial of JYB1904 Injection in Adolescent Participants

U.S., April 8 -- ClinicalTrials.gov registry received information related to the study (NCT07513857) titled 'Trial of JYB1904 Injection in Adolescent Participants' on March 27. Brief Summary: This Ph... Read More

Clinical Trial: From Global Balance Metrics to Plane-Specific Signatures: Identifying Postural Instability Phenotypes in Females

U.S., April 8 -- ClinicalTrials.gov registry received information related to the study (NCT07516197) titled 'From Global Balance Metrics to Plane-Specific Signatures: Identifying Postural Instability ... Read More

Clinical Trial: Improving Sleep Health Outcomes for Family Caregivers

U.S., April 8 -- ClinicalTrials.gov registry received information related to the study (NCT07513246) titled 'Improving Sleep Health Outcomes for Family Caregivers' on April 01. Brief Summary: This pi... Read More

Clinical Trial: Risk Stratification of Cancer Therapy-Related Cardiac Dysfunction Using AI-Enhanced Electrocardiography

U.S., April 8 -- ClinicalTrials.gov registry received information related to the study (NCT07515859) titled 'Risk Stratification of Cancer Therapy-Related Cardiac Dysfunction Using AI-Enhanced Electro... Read More

Singapore Clinical Trial: A Phase 1, 2-Part Study to Determine the Effect of Injection Site on the Relative Bioavailability of a Single Subcutaneous Dose of LY3537031 and to Evaluate the Pharmacokinetics of a Single Intravenous Dose of LY3537031 in Healthy Participants

Singapore, April 8 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, 2-Part Study to Determine the Effect of Injection Site on the Relative Bioavailability ... Read More

Singapore Clinical Trial: A Phase 1, 2-Part Study to Determine the Effect of Injection Site on the Relative Bioavailability of a Single Subcutaneous Dose of LY3537031 and to Evaluate the Pharmacokinetics of a Single Intravenous Dose of LY3537031 in Healthy Participants

Singapore, April 8 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, 2-Part Study to Determine the Effect of Injection Site on the Relative Bioavailability ... Read More

Singapore Clinical Trial: A Phase 3 Randomized, Open-label Study to Evaluate the Efficacy and Safety of sac-TMT (Sacituzumab Tirumotecan, MK-2870) Followed by Carboplatin/Paclitaxel vs Chemotherapy, Both in Combination With Pembrolizumab as Neoadjuvant Therapy for High-Risk, Early-Stage, Triple-Negative Breast Cancer or Hormone Receptor-low Positive/Human Epidermal Growth Factor Receptor-2 Negative Breast Cancer

Singapore, April 8 -- The Health Sciences Authority received information related to the study titled 'A Phase 3 Randomized, Open-label Study to Evaluate the Efficacy and Safety of sac-TMT (Sacituzumab... Read More

Singapore Clinical Trial: A Global, Phase 3, Randomized, Multicenter, Open-Label Study to Evaluate the Efficacy and Safety of Firmonertinib Compared with Investigator’s Choice of Osimertinib or Afatinib as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic Non-Small-Cell Lung Cancer with Epidermal Growth Factor Receptor P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations (ALPACCA)

Singapore, April 8 -- The Health Sciences Authority received information related to the study titled 'A Global, Phase 3, Randomized, Multicenter, Open-Label Study to Evaluate the Efficacy and Safety o... Read More

• ««
• «
• 106
• 107
• 108
• 109
• 110
• 111
• 112
• 113
• 114
• 115
• »
• »»